戻る Agenda
SLS05 ICH Anniversary: Summary of 30 Years and Future Prospects in S Area with Role of Japan
Session Chair(s)
Yoko Hirabayashi, MD
Division Head, National Institute of Health Sciences, Japan
Kazuto Watanabe, PHD
Translational Research Division Principal Scientist, Chugai pharmaceutical Co, LTD, Japan
Speaker(s)
Kazushige Maki, DVM, PHD
Senior Scientist, Toxicology, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Takuya Nishimura, PHD
Principal Reviewer, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Shigeru Hisada
Innovative Drug Discovery Division, ASKA Pharmaceutical Co, Ltd , Japan
Joy A. Cavagnaro, PHD
President, Access BIO, United States